沈 武典

Medicine & Life Sciences

1. Antidepressive Agents 100%
2. Bipolar Disorder 92%
3. Taiwan 87%
4. Antipsychotic Agents 83%
5. Bibliometrics 66%
6. Psychiatry 62%
7. Major Depressive Disorder 62%
8. Prescriptions 60%
9. Olanzapine 52%
10. Lithium 47%
11. Depression 46%
12. Schizophrenia 40%
13. Citalopram 38%
14. Clozapine 30%
15. General Hospitals 30%
16. Aripiprazole 28%
17. Risperidone 27%
18. Therapeutics 26%
19. Pharmaceutical Preparations 26%
20. Paroxetine 26%
21. Mental Disorders 25%
22. Psychiatric Hospitals 25%
23. Singapore 25%
24. Post-Traumatic Stress Disorders 23%
25. Health Expenditures 23%
26. Genetic Polymorphisms 22%
27. Omega-3 Fatty Acids 21%
28. Alcoholism 20%
29. Quetiapine Fumarate 20%
30. Unsaturated Fatty Acids 20%
31. Complementary Therapies 19%
32. Serum 19%
33. Pharmacology 19%
34. Asenapine 19%
35. Depressive Disorder 19%
36. Lurasidone Hydrochloride 18%
37. Inpatients 18%
38. Psychotic Disorders 17%
39. Benzodiazepines 17%
40. Demography 17%
41. Publications 17%
42. Dendritic Cells 17%
43. Wakefulness-Promoting Agents 17%
44. Health 16%
45. Interleukin-10 16%
46. ziprasidone 16%
47. Pityriasis Rosea 16%
48. Cytochrome P-450 CYP2D6 16%
49. Quality of Life 15%